John E Donello
Inventor
Stats
- 121 US patents issued
- 227 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 121 US Patents Issued
- 227 US Applications Filed
- 838 Total Citation Count
- Mar 11, 2024 Most Recent Filing
- Feb 14, 2001 Earliest Filing
Work History
Patent Owner | Applications Filed | Year |
---|---|---|
ALLERGAN, INC. | 2
4 9 12 10 14 21 6 17 34 43 44 27 22 10 11 | 2002
2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 |
ALLERGAN SALES, INC. | 2
| 2001
|
CELANDYNE, LLC | 1
| 2013
|
EXONHIT THERAPEUTICS SA | 6
2 2 2 11 4 2 4 | 2006
2008 2009 2011 2012 2013 2014 2015 |
Inventor Addresses
Address | Duration |
---|---|
DANA POINT, CA, US | Jul 25, 13 - Apr 09, 20 |
Dana Point, CA | Sep 25, 01 - Dec 18, 08 |
Dana Point, CA, US | Oct 18, 01 - Dec 05, 24 |
San Clemente, CA, US | Oct 02, 14 - Apr 05, 16 |
Technology Profile
Technology | Matters | |
---|---|---|
A01N: | PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF | 20 |
A61F: | FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS | 1 |
A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 198 |
Patents / Publication
Patents / Publication # | Year of Publication / Issued | Title | Citations |
---|---|---|---|
2024/0400,501 | 2024 | 3,4-DISUBSTITUTED 3-CYCLOBUTENE-1,2-DIONES AND USE THEREOF | 0 |
2024/0285,584 | 2024 | AMIDE DERIVATIVES OF N-UREA SUBSTITUTED AMINO ACIDS AS FORMYL PEPTIDERECEPTOR LIKE-1 (FPRL-1) RECEPTOR MODULATORS | 0 |
2023/0062,049 | 2023 | METHODS OF TREATING ALPHA ADRENERGIC MEDIATED CONDITIONS | 0 |
2022/0402,866 | 2022 | 3,4-DISUBSTITUTED 3-CYCLOBUTENE-1,2-DIONES AND USE THEREOF | 1 |
2022/0233,505 | 2022 | PHARMACEUTICAL COMPOSITIONS COMPRISING 4-[1-(2,3-DIMETHYLPHENYL)ETHYL]-3H-IMIDAZOLE DERIVATIVES FOR TREATING RETINAL DISEASES | 0 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.